Effects of Hydrocortisone, Melatonin, and Placebo on Jet Lag
NCT00097474 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 57
Last updated 2026-05-07
Summary
This study will examine the effects of cortisol (hydrocortisone), melatonin, a combination of cortisol and melatonin, and placebo (an inactive substance) on jet lag symptoms. Jet lag is a term used to describe symptoms people commonly experience after rapid travel across several time zones. The cause of jet lag is not known, but various hormones, including cortisol and melatonin, have a day-to-night pattern of secretion and play a role in maintaining the body's internal rhythms. This study will test whether taking cortisol, melatonin, or both can help re-establish the body's day-night cycle and result in less jet lag.
People between 18 and 65 years of age who are planning a non-stop eastward flight with the following characteristics may be eligible for this study:
* Crossing six to eight time zones (6 to 8 hours difference between Eastern Standard Time and the destination)
* Destination between 30 and 50 latitudes (approximately Cairo to London)
* Evening flight (5 PM to midnight) with morning arrival
* Remaining abroad at least 4-10 days
Candidates must have a body mass index (BMI) between 20 and 30 kg/M (not too thin and not overweight) and must not be taking medicines that affect sleep or cortisol or melatonin levels. Prospective participants are screened with a medical history, blood tests, and check of blood pressure, height, and weight.
Pre-flight Procedures
Participants keep a sleep journal 3 days before the flight. For 1 day within 3 days of the flight they fill out jet lag and sleepiness questionnaires and collect morning and bedtime saliva samples for measurement of cortisol and melatonin. The saliva is collected by chewing on two small cotton pads and spitting them into a tube. Premenopausal women provide a urine sample the week before the flight to test for pregnancy. On the day of the flight, the participants do not collect saliva or fill out sleep logs or questionnaires. They are given two bottles with study medication. One bottle, labeled "AM," contains either hydrocortisone or placebo; the other, labeled "PM," contains either melatonin or placebo.
Post-flight Procedures
Upon arriving at their destination in the morning, participants obtain a saliva sample and take one of the capsules in the "AM" bottle. At bedtime, they collect saliva and then take one of the "PM" capsules. They repeat the medication doses for a total of 4 days and repeat the saliva collections on days 2 through 4, 7 and 10 after arrival. In addition, participants complete jet lag and sleep questionnaires in the morning, afternoon, and just before bedtime on the day of arrival and on days 2 through 4, 7 and 10.
After they return from their trip, participants are seen at the NIH Clinic to bring in their saliva specimens and review their questionnaires with study investigators.
...
Conditions
- Jet Lag
Interventions
- DRUG
-
Hydrocortisone
Hydrocortisone will be given alone or in combination with Melatonin to see if symptoms of jet lag are alleviated
- DRUG
-
Melatonin
Melatonin will be given alone or in combination with Hydrocortisone to see if symptoms of jet lag are alleviated
- DRUG
-
Placebo
Sponsors & Collaborators
-
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
lead NIH
Principal Investigators
-
Lynnette K Nieman, M.D. · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-12-21
- Primary Completion
- 2006-01-06
- Completion
- 2007-11-14
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Evaluating the Effects of Tasimelteon vs. Placebo on Jet Lag Type Insomnia
NCT03373201 ·Status: COMPLETED ·Phase: PHASE3
-
Acute Concussion and Melatonin
NCT04731974 ·Status: RECRUITING ·Phase: PHASE2
-
A Proof of Concept Study to Evaluate the Effects of Tasimelteon and Placebo in Travelers With Jet Lag Disorder
NCT03291041 ·Status: COMPLETED ·Phase: PHASE2
-
Melatonin and Nighttime Blood Pressure in African Americans--24 mg Study
NCT01114373 ·Status: COMPLETED ·Phase: PHASE2
-
Circadian Phase Adjustment and Improvement of Metabolic Control in Night Shift Workers
NCT02108353 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment for Sleep Disturbance in Orthopaedic Trauma Patients
NCT03779243 ·Status: COMPLETED ·Phase: NA
-
Melatonin Treatment for Night-Eating Syndrome
NCT02500017 ·Status: TERMINATED ·Phase: NA
-
Effect of a Novel Melatonin Supplement on Sleep Quality
NCT06215573 ·Status: COMPLETED ·Phase: NA
-
Study of the Effect of Armodafinil Treatment in Healthy Subjects With Excessive Sleepiness Associated With Jet Lag Disorder
NCT00758498 ·Status: COMPLETED ·Phase: PHASE3
-
Prevention of Delirium in Intensive Care by Melatonin
NCT03524937 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Behavioral and Pharmacological Reconsolidation Interference in Misophonia
NCT05928689 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Optimize Astronaut Sleep Medication Efficacy and Individual Effects
NCT03526575 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Melatonin, Low-dose Quetiapine, or Placebo in Patients With Psychiatric Disorders and Comorbid Insomnia
NCT06062953 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Melatonin and the Metabolic Syndrome
NCT01038921 ·Status: COMPLETED ·Phase: PHASE2
-
Melatonin 3mg and 5mg Compared to Cognitive Behavioral Therapy for Insomnia (CBT-I) in the Treatment of Insomnia
NCT02798367 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Functional Melatonin Replacement for Sleep Disruptions in Individuals With Tetraplegia
NCT00507546 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Oral BTD-001 in Adults With Idiopathic Hypersomnia
NCT03542851 ·Status: UNKNOWN ·Phase: PHASE2
-
Effect of Slow-release Melatonin (Circadin®) Therapy on Idiopathic RBD: a Pilot Study
NCT02836743 ·Status: UNKNOWN ·Phase: PHASE4
-
Ramelteon for a Nap Prior to a Night Shift
NCT00595075 ·Status: COMPLETED ·Phase: NA
-
SM-1 vs 2 Comparators and Placebo in Participants With a History of Transient Insomnia.
NCT03331042 ·Status: COMPLETED ·Phase: PHASE3
-
Melatonin for Delirium Prophylaxis
NCT02282241 ·Status: WITHDRAWN ·Phase: PHASE4
-
Melatonin and Nighttime Blood Pressure in African Americans-8 mg Study
NCT01114360 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Trial on a Food Supplement With Melatonin and Herbal Products to Improve Sleep Quality
NCT05459272 ·Status: UNKNOWN ·Phase: NA
-
Melatonin for Treatment of Delirium in Critically Ill Adult Patients
NCT05713877 ·Status: RECRUITING ·Phase: PHASE2
-
Use of Endogenous Melatonin and 6-hydroxymelatonin as Biomarkers for CYP1A2
NCT04420611 ·Status: COMPLETED